ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ETS1
|
ENSG00000134954.10 | ETS1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ETS1 | hg19_v2_chr11_-_128392085_128392232 | 0.34 | 2.0e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_-_46756351 | 3.47 |
ENST00000323076.2 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
chr1_-_111743285 | 3.32 |
ENST00000357640.4 |
DENND2D |
DENN/MADD domain containing 2D |
chr2_+_33661382 | 3.25 |
ENST00000402538.3 |
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated) |
chr21_-_46340770 | 3.09 |
ENST00000397854.3 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr17_-_38721711 | 2.97 |
ENST00000578085.1 ENST00000246657.2 |
CCR7 |
chemokine (C-C motif) receptor 7 |
chr2_-_175499294 | 2.82 |
ENST00000392547.2 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
chr17_-_29641104 | 2.63 |
ENST00000577894.1 ENST00000330927.4 |
EVI2B |
ecotropic viral integration site 2B |
chr22_-_37545972 | 2.51 |
ENST00000216223.5 |
IL2RB |
interleukin 2 receptor, beta |
chr3_-_16555150 | 2.41 |
ENST00000334133.4 |
RFTN1 |
raftlin, lipid raft linker 1 |
chr17_-_29641084 | 2.39 |
ENST00000544462.1 |
EVI2B |
ecotropic viral integration site 2B |
chr12_+_25205568 | 2.38 |
ENST00000548766.1 ENST00000556887.1 |
LRMP |
lymphoid-restricted membrane protein |
chr19_-_10450287 | 2.34 |
ENST00000589261.1 ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3 |
intercellular adhesion molecule 3 |
chr15_+_81589254 | 2.32 |
ENST00000394652.2 |
IL16 |
interleukin 16 |
chr15_+_75074410 | 2.32 |
ENST00000439220.2 |
CSK |
c-src tyrosine kinase |
chr19_+_1077393 | 2.27 |
ENST00000590577.1 |
HMHA1 |
histocompatibility (minor) HA-1 |
chr19_+_42381337 | 2.27 |
ENST00000597454.1 ENST00000444740.2 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
chr12_+_25205666 | 2.25 |
ENST00000547044.1 |
LRMP |
lymphoid-restricted membrane protein |
chr16_+_30483962 | 2.24 |
ENST00000356798.6 |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr7_-_150329421 | 2.22 |
ENST00000493969.1 ENST00000328902.5 |
GIMAP6 |
GTPase, IMAP family member 6 |
chr1_-_183559693 | 2.22 |
ENST00000367535.3 ENST00000413720.1 ENST00000418089.1 |
NCF2 |
neutrophil cytosolic factor 2 |
chr14_-_69864993 | 2.22 |
ENST00000555373.1 |
ERH |
enhancer of rudimentary homolog (Drosophila) |
chr1_-_25256368 | 2.17 |
ENST00000308873.6 |
RUNX3 |
runt-related transcription factor 3 |
chr11_+_60223312 | 2.16 |
ENST00000532491.1 ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1 |
membrane-spanning 4-domains, subfamily A, member 1 |
chr11_+_60223225 | 2.16 |
ENST00000524807.1 ENST00000345732.4 |
MS4A1 |
membrane-spanning 4-domains, subfamily A, member 1 |
chr1_+_32716840 | 2.11 |
ENST00000336890.5 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr12_+_7055631 | 2.10 |
ENST00000543115.1 ENST00000399448.1 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
chr1_-_183560011 | 2.09 |
ENST00000367536.1 |
NCF2 |
neutrophil cytosolic factor 2 |
chr10_-_98031265 | 2.04 |
ENST00000224337.5 ENST00000371176.2 |
BLNK |
B-cell linker |
chr16_-_88717482 | 2.04 |
ENST00000261623.3 |
CYBA |
cytochrome b-245, alpha polypeptide |
chr1_-_31230650 | 2.03 |
ENST00000294507.3 |
LAPTM5 |
lysosomal protein transmembrane 5 |
chr2_+_182321925 | 2.01 |
ENST00000339307.4 ENST00000397033.2 |
ITGA4 |
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
chr1_+_32716857 | 2.01 |
ENST00000482949.1 ENST00000495610.2 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr19_+_42381173 | 2.00 |
ENST00000221972.3 |
CD79A |
CD79a molecule, immunoglobulin-associated alpha |
chr10_-_98031310 | 1.97 |
ENST00000427367.2 ENST00000413476.2 |
BLNK |
B-cell linker |
chr14_-_23285011 | 1.96 |
ENST00000397532.3 |
SLC7A7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr12_+_7055767 | 1.95 |
ENST00000447931.2 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
chr19_-_39826639 | 1.95 |
ENST00000602185.1 ENST00000598034.1 ENST00000601387.1 ENST00000595636.1 ENST00000253054.8 ENST00000594700.1 ENST00000597595.1 |
GMFG |
glia maturation factor, gamma |
chr1_-_173174681 | 1.91 |
ENST00000367718.1 |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
chr1_+_32739733 | 1.91 |
ENST00000333070.4 |
LCK |
lymphocyte-specific protein tyrosine kinase |
chr12_+_25205446 | 1.91 |
ENST00000557489.1 ENST00000354454.3 ENST00000536173.1 |
LRMP |
lymphoid-restricted membrane protein |
chr17_-_56595196 | 1.89 |
ENST00000579921.1 ENST00000579925.1 ENST00000323456.5 |
MTMR4 |
myotubularin related protein 4 |
chr8_+_38585704 | 1.85 |
ENST00000519416.1 ENST00000520615.1 |
TACC1 |
transforming, acidic coiled-coil containing protein 1 |
chr3_-_121379739 | 1.83 |
ENST00000428394.2 ENST00000314583.3 |
HCLS1 |
hematopoietic cell-specific Lyn substrate 1 |
chr2_+_143886877 | 1.81 |
ENST00000295095.6 |
ARHGAP15 |
Rho GTPase activating protein 15 |
chr15_-_80263506 | 1.79 |
ENST00000335661.6 |
BCL2A1 |
BCL2-related protein A1 |
chr4_-_84035868 | 1.79 |
ENST00000426923.2 ENST00000509973.1 |
PLAC8 |
placenta-specific 8 |
chr21_-_46340884 | 1.74 |
ENST00000302347.5 ENST00000517819.1 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr14_-_23285069 | 1.74 |
ENST00000554758.1 ENST00000397528.4 |
SLC7A7 |
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr4_-_84035905 | 1.74 |
ENST00000311507.4 |
PLAC8 |
placenta-specific 8 |
chr6_-_32160622 | 1.69 |
ENST00000487761.1 ENST00000375040.3 |
GPSM3 |
G-protein signaling modulator 3 |
chr8_+_74903580 | 1.68 |
ENST00000284818.2 ENST00000518893.1 |
LY96 |
lymphocyte antigen 96 |
chr13_-_33760216 | 1.65 |
ENST00000255486.4 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
chr2_-_175462934 | 1.62 |
ENST00000392546.2 ENST00000436221.1 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
chr19_-_10450328 | 1.62 |
ENST00000160262.5 |
ICAM3 |
intercellular adhesion molecule 3 |
chr5_-_88179302 | 1.62 |
ENST00000504921.2 |
MEF2C |
myocyte enhancer factor 2C |
chr5_+_156693091 | 1.59 |
ENST00000318218.6 ENST00000442283.2 ENST00000522463.1 ENST00000521420.1 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
chr1_-_207095324 | 1.59 |
ENST00000530505.1 ENST00000367091.3 ENST00000442471.2 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
chrX_-_15872914 | 1.58 |
ENST00000380291.1 ENST00000545766.1 ENST00000421527.2 ENST00000329235.2 |
AP1S2 |
adaptor-related protein complex 1, sigma 2 subunit |
chr16_+_81812863 | 1.57 |
ENST00000359376.3 |
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
chr2_-_225811747 | 1.54 |
ENST00000409592.3 |
DOCK10 |
dedicator of cytokinesis 10 |
chr2_+_68592305 | 1.51 |
ENST00000234313.7 |
PLEK |
pleckstrin |
chrX_-_70331298 | 1.46 |
ENST00000456850.2 ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG |
interleukin 2 receptor, gamma |
chr16_-_88717423 | 1.44 |
ENST00000568278.1 ENST00000569359.1 ENST00000567174.1 |
CYBA |
cytochrome b-245, alpha polypeptide |
chr5_+_156693159 | 1.44 |
ENST00000347377.6 |
CYFIP2 |
cytoplasmic FMR1 interacting protein 2 |
chr8_-_77912431 | 1.44 |
ENST00000357039.4 ENST00000522527.1 |
PEX2 |
peroxisomal biogenesis factor 2 |
chr1_+_111415757 | 1.43 |
ENST00000429072.2 ENST00000271324.5 |
CD53 |
CD53 molecule |
chr5_-_88178964 | 1.39 |
ENST00000513252.1 ENST00000508569.1 ENST00000510942.1 ENST00000506554.1 |
MEF2C |
myocyte enhancer factor 2C |
chr12_-_53601055 | 1.39 |
ENST00000552972.1 ENST00000422257.3 ENST00000267082.5 |
ITGB7 |
integrin, beta 7 |
chr12_-_53601000 | 1.38 |
ENST00000338737.4 ENST00000549086.2 |
ITGB7 |
integrin, beta 7 |
chr2_-_175462456 | 1.34 |
ENST00000409891.1 ENST00000410117.1 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
chr17_-_46507567 | 1.32 |
ENST00000584924.1 |
SKAP1 |
src kinase associated phosphoprotein 1 |
chr21_-_15918618 | 1.31 |
ENST00000400564.1 ENST00000400566.1 |
SAMSN1 |
SAM domain, SH3 domain and nuclear localization signals 1 |
chrX_+_77166172 | 1.28 |
ENST00000343533.5 ENST00000350425.4 ENST00000341514.6 |
ATP7A |
ATPase, Cu++ transporting, alpha polypeptide |
chr12_-_719573 | 1.28 |
ENST00000397265.3 |
NINJ2 |
ninjurin 2 |
chr13_+_111806083 | 1.28 |
ENST00000375736.4 |
ARHGEF7 |
Rho guanine nucleotide exchange factor (GEF) 7 |
chr17_-_46507537 | 1.27 |
ENST00000336915.6 |
SKAP1 |
src kinase associated phosphoprotein 1 |
chr5_-_88179017 | 1.25 |
ENST00000514028.1 ENST00000514015.1 ENST00000503075.1 ENST00000437473.2 |
MEF2C |
myocyte enhancer factor 2C |
chrX_+_128913906 | 1.25 |
ENST00000356892.3 |
SASH3 |
SAM and SH3 domain containing 3 |
chr15_+_75074385 | 1.25 |
ENST00000220003.9 |
CSK |
c-src tyrosine kinase |
chr1_-_207095212 | 1.23 |
ENST00000420007.2 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
chr3_-_105588231 | 1.23 |
ENST00000545639.1 ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chr3_+_179065474 | 1.23 |
ENST00000471841.1 ENST00000280653.7 |
MFN1 |
mitofusin 1 |
chr11_+_102188224 | 1.23 |
ENST00000263464.3 |
BIRC3 |
baculoviral IAP repeat containing 3 |
chr1_+_236305826 | 1.21 |
ENST00000366592.3 ENST00000366591.4 |
GPR137B |
G protein-coupled receptor 137B |
chr19_+_49838653 | 1.20 |
ENST00000598095.1 ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37 |
CD37 molecule |
chr1_-_150738261 | 1.19 |
ENST00000448301.2 ENST00000368985.3 |
CTSS |
cathepsin S |
chr14_-_90085458 | 1.18 |
ENST00000345097.4 ENST00000555855.1 ENST00000555353.1 |
FOXN3 |
forkhead box N3 |
chr11_+_102188272 | 1.18 |
ENST00000532808.1 |
BIRC3 |
baculoviral IAP repeat containing 3 |
chr4_+_68424434 | 1.18 |
ENST00000265404.2 ENST00000396225.1 |
STAP1 |
signal transducing adaptor family member 1 |
chr5_+_133984462 | 1.17 |
ENST00000398844.2 ENST00000322887.4 |
SEC24A |
SEC24 family member A |
chr6_-_27440837 | 1.17 |
ENST00000211936.6 |
ZNF184 |
zinc finger protein 184 |
chr22_+_37257015 | 1.16 |
ENST00000447071.1 ENST00000248899.6 ENST00000397147.4 |
NCF4 |
neutrophil cytosolic factor 4, 40kDa |
chr2_+_204193101 | 1.16 |
ENST00000430418.1 ENST00000424558.1 ENST00000261016.6 |
ABI2 |
abl-interactor 2 |
chr7_-_5569588 | 1.16 |
ENST00000417101.1 |
ACTB |
actin, beta |
chr1_+_198608146 | 1.15 |
ENST00000367376.2 ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
chr19_-_39108568 | 1.15 |
ENST00000586296.1 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
chr17_+_10600894 | 1.14 |
ENST00000379774.4 |
ADPRM |
ADP-ribose/CDP-alcohol diphosphatase, manganese-dependent |
chr8_-_119964434 | 1.09 |
ENST00000297350.4 |
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
chr6_-_27440460 | 1.07 |
ENST00000377419.1 |
ZNF184 |
zinc finger protein 184 |
chr13_+_111806055 | 1.06 |
ENST00000218789.5 |
ARHGEF7 |
Rho guanine nucleotide exchange factor (GEF) 7 |
chr12_-_6798616 | 1.05 |
ENST00000355772.4 ENST00000417772.3 ENST00000396801.3 ENST00000396799.2 |
ZNF384 |
zinc finger protein 384 |
chr11_-_67205538 | 1.03 |
ENST00000326294.3 |
PTPRCAP |
protein tyrosine phosphatase, receptor type, C-associated protein |
chr9_-_88969303 | 1.02 |
ENST00000277141.6 ENST00000375963.3 |
ZCCHC6 |
zinc finger, CCHC domain containing 6 |
chr7_-_37488834 | 1.02 |
ENST00000310758.4 |
ELMO1 |
engulfment and cell motility 1 |
chr2_-_238322770 | 1.01 |
ENST00000472056.1 |
COL6A3 |
collagen, type VI, alpha 3 |
chr10_+_12391481 | 1.01 |
ENST00000378847.3 |
CAMK1D |
calcium/calmodulin-dependent protein kinase ID |
chr11_+_22688150 | 1.00 |
ENST00000454584.2 |
GAS2 |
growth arrest-specific 2 |
chr13_+_31191920 | 0.99 |
ENST00000255304.4 |
USPL1 |
ubiquitin specific peptidase like 1 |
chr12_-_51717875 | 0.99 |
ENST00000604560.1 |
BIN2 |
bridging integrator 2 |
chr2_+_204193149 | 0.98 |
ENST00000422511.2 |
ABI2 |
abl-interactor 2 |
chr9_-_88969339 | 0.98 |
ENST00000375960.2 ENST00000375961.2 |
ZCCHC6 |
zinc finger, CCHC domain containing 6 |
chr2_-_238322800 | 0.98 |
ENST00000392004.3 ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3 |
collagen, type VI, alpha 3 |
chr16_+_50300427 | 0.97 |
ENST00000394697.2 ENST00000566433.2 ENST00000538642.1 |
ADCY7 |
adenylate cyclase 7 |
chr1_+_12185949 | 0.97 |
ENST00000413146.2 |
TNFRSF8 |
tumor necrosis factor receptor superfamily, member 8 |
chr18_-_52989525 | 0.96 |
ENST00000457482.3 |
TCF4 |
transcription factor 4 |
chr1_-_25558963 | 0.95 |
ENST00000354361.3 |
SYF2 |
SYF2 pre-mRNA-splicing factor |
chr19_+_6772710 | 0.95 |
ENST00000304076.2 ENST00000602142.1 ENST00000596764.1 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
chr17_-_16875371 | 0.95 |
ENST00000437538.2 ENST00000583789.1 ENST00000261652.2 ENST00000579315.1 |
TNFRSF13B |
tumor necrosis factor receptor superfamily, member 13B |
chrX_+_48542168 | 0.94 |
ENST00000376701.4 |
WAS |
Wiskott-Aldrich syndrome |
chr2_-_110371664 | 0.94 |
ENST00000545389.1 ENST00000423520.1 |
SEPT10 |
septin 10 |
chr20_-_57582296 | 0.93 |
ENST00000217131.5 |
CTSZ |
cathepsin Z |
chr5_+_133451254 | 0.93 |
ENST00000517851.1 ENST00000521639.1 ENST00000522375.1 ENST00000378560.4 ENST00000432532.2 ENST00000520958.1 ENST00000518915.1 ENST00000395023.1 |
TCF7 |
transcription factor 7 (T-cell specific, HMG-box) |
chr12_+_58138664 | 0.93 |
ENST00000257910.3 |
TSPAN31 |
tetraspanin 31 |
chr12_+_75874984 | 0.92 |
ENST00000550491.1 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr2_+_231090433 | 0.92 |
ENST00000486687.2 ENST00000350136.5 ENST00000392045.3 ENST00000417495.3 ENST00000343805.6 ENST00000420434.3 |
SP140 |
SP140 nuclear body protein |
chr7_+_99156314 | 0.91 |
ENST00000425063.1 ENST00000493277.1 |
ZNF655 |
zinc finger protein 655 |
chr10_+_63661053 | 0.90 |
ENST00000279873.7 |
ARID5B |
AT rich interactive domain 5B (MRF1-like) |
chr12_-_51717948 | 0.90 |
ENST00000267012.4 |
BIN2 |
bridging integrator 2 |
chr12_-_51717922 | 0.89 |
ENST00000452142.2 |
BIN2 |
bridging integrator 2 |
chr3_-_178790057 | 0.88 |
ENST00000311417.2 |
ZMAT3 |
zinc finger, matrin-type 3 |
chr7_+_99156434 | 0.88 |
ENST00000424881.1 ENST00000440391.1 ENST00000394163.2 |
ZNF655 |
zinc finger protein 655 |
chr2_+_204193129 | 0.88 |
ENST00000417864.1 |
ABI2 |
abl-interactor 2 |
chr2_-_238323007 | 0.88 |
ENST00000295550.4 |
COL6A3 |
collagen, type VI, alpha 3 |
chr10_+_124320156 | 0.87 |
ENST00000338354.3 ENST00000344338.3 ENST00000330163.4 ENST00000368909.3 ENST00000368955.3 ENST00000368956.2 |
DMBT1 |
deleted in malignant brain tumors 1 |
chr10_+_114135952 | 0.87 |
ENST00000356116.1 ENST00000433418.1 ENST00000354273.4 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
chr12_-_93835665 | 0.86 |
ENST00000552442.1 ENST00000550657.1 |
UBE2N |
ubiquitin-conjugating enzyme E2N |
chr7_+_2281843 | 0.86 |
ENST00000356714.1 ENST00000397049.1 |
NUDT1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 1 |
chr12_-_51566562 | 0.86 |
ENST00000548108.1 |
TFCP2 |
transcription factor CP2 |
chr4_-_39033963 | 0.86 |
ENST00000381938.3 |
TMEM156 |
transmembrane protein 156 |
chr19_-_6481776 | 0.85 |
ENST00000543576.1 ENST00000590173.1 ENST00000381480.2 |
DENND1C |
DENN/MADD domain containing 1C |
chrX_-_70838306 | 0.85 |
ENST00000373691.4 ENST00000373693.3 |
CXCR3 |
chemokine (C-X-C motif) receptor 3 |
chr22_-_36877371 | 0.85 |
ENST00000403313.1 |
TXN2 |
thioredoxin 2 |
chr12_+_75874580 | 0.85 |
ENST00000456650.3 |
GLIPR1 |
GLI pathogenesis-related 1 |
chr12_+_53693812 | 0.84 |
ENST00000549488.1 |
C12orf10 |
chromosome 12 open reading frame 10 |
chr3_-_69101461 | 0.84 |
ENST00000543976.1 |
TMF1 |
TATA element modulatory factor 1 |
chrX_+_51546103 | 0.82 |
ENST00000375772.3 |
MAGED1 |
melanoma antigen family D, 1 |
chr5_+_153570285 | 0.82 |
ENST00000425427.2 ENST00000297107.6 |
GALNT10 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) |
chr12_-_6798410 | 0.82 |
ENST00000361959.3 ENST00000436774.2 ENST00000544482.1 |
ZNF384 |
zinc finger protein 384 |
chr5_+_153570319 | 0.81 |
ENST00000377661.2 |
GALNT10 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) |
chr3_-_178789993 | 0.81 |
ENST00000432729.1 |
ZMAT3 |
zinc finger, matrin-type 3 |
chr2_+_65216462 | 0.80 |
ENST00000234256.3 |
SLC1A4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
chr7_+_2281882 | 0.80 |
ENST00000397046.1 ENST00000397048.1 ENST00000454650.1 |
NUDT1 |
nudix (nucleoside diphosphate linked moiety X)-type motif 1 |
chr12_+_58138800 | 0.79 |
ENST00000547992.1 ENST00000552816.1 ENST00000547472.1 |
TSPAN31 |
tetraspanin 31 |
chr12_-_6798523 | 0.79 |
ENST00000319770.3 |
ZNF384 |
zinc finger protein 384 |
chr3_-_69101413 | 0.79 |
ENST00000398559.2 |
TMF1 |
TATA element modulatory factor 1 |
chr1_-_25558984 | 0.79 |
ENST00000236273.4 |
SYF2 |
SYF2 pre-mRNA-splicing factor |
chr18_-_52989217 | 0.79 |
ENST00000570287.2 |
TCF4 |
transcription factor 4 |
chr10_+_124320195 | 0.78 |
ENST00000359586.6 |
DMBT1 |
deleted in malignant brain tumors 1 |
chr12_+_53693466 | 0.78 |
ENST00000267103.5 ENST00000548632.1 |
C12orf10 |
chromosome 12 open reading frame 10 |
chr19_-_39108552 | 0.78 |
ENST00000591517.1 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
chr7_-_128694927 | 0.78 |
ENST00000471166.1 ENST00000265388.5 |
TNPO3 |
transportin 3 |
chr17_+_16318909 | 0.78 |
ENST00000577397.1 |
TRPV2 |
transient receptor potential cation channel, subfamily V, member 2 |
chr5_+_102455968 | 0.78 |
ENST00000358359.3 |
PPIP5K2 |
diphosphoinositol pentakisphosphate kinase 2 |
chr5_+_118407053 | 0.78 |
ENST00000311085.8 ENST00000539542.1 |
DMXL1 |
Dmx-like 1 |
chr14_+_69865401 | 0.78 |
ENST00000556605.1 ENST00000336643.5 ENST00000031146.4 |
SLC39A9 |
solute carrier family 39, member 9 |
chr11_-_62389449 | 0.76 |
ENST00000534026.1 |
B3GAT3 |
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
chr17_+_16318850 | 0.76 |
ENST00000338560.7 |
TRPV2 |
transient receptor potential cation channel, subfamily V, member 2 |
chr2_+_231729615 | 0.75 |
ENST00000326427.6 ENST00000335005.6 ENST00000326407.6 |
ITM2C |
integral membrane protein 2C |
chr5_-_169725231 | 0.75 |
ENST00000046794.5 |
LCP2 |
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr2_+_118846008 | 0.74 |
ENST00000245787.4 |
INSIG2 |
insulin induced gene 2 |
chr17_+_43299241 | 0.74 |
ENST00000328118.3 |
FMNL1 |
formin-like 1 |
chr19_-_39108643 | 0.73 |
ENST00000396857.2 |
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1 |
chr12_+_53773944 | 0.73 |
ENST00000551969.1 ENST00000327443.4 |
SP1 |
Sp1 transcription factor |
chr12_-_105630016 | 0.73 |
ENST00000258530.3 |
APPL2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
chr2_+_204192942 | 0.72 |
ENST00000295851.5 ENST00000261017.5 |
ABI2 |
abl-interactor 2 |
chr12_-_92539614 | 0.72 |
ENST00000256015.3 |
BTG1 |
B-cell translocation gene 1, anti-proliferative |
chr4_-_100867864 | 0.71 |
ENST00000442697.2 |
DNAJB14 |
DnaJ (Hsp40) homolog, subfamily B, member 14 |
chr11_+_118230287 | 0.71 |
ENST00000252108.3 ENST00000431736.2 |
UBE4A |
ubiquitination factor E4A |
chr4_+_75858318 | 0.71 |
ENST00000307428.7 |
PARM1 |
prostate androgen-regulated mucin-like protein 1 |
chr5_+_112312416 | 0.71 |
ENST00000389063.2 |
DCP2 |
decapping mRNA 2 |
chr12_+_108908962 | 0.70 |
ENST00000552695.1 ENST00000552758.1 ENST00000361549.2 |
FICD |
FIC domain containing |
chr17_+_43299156 | 0.70 |
ENST00000331495.3 |
FMNL1 |
formin-like 1 |
chrX_+_154114635 | 0.70 |
ENST00000369446.2 |
F8A1 |
coagulation factor VIII-associated 1 |
chr8_+_86089460 | 0.70 |
ENST00000418930.2 |
E2F5 |
E2F transcription factor 5, p130-binding |
chr11_+_5617952 | 0.69 |
ENST00000354852.5 |
TRIM6-TRIM34 |
TRIM6-TRIM34 readthrough |
chr16_+_20817839 | 0.69 |
ENST00000348433.6 ENST00000568501.1 ENST00000566276.1 |
AC004381.6 |
Putative RNA exonuclease NEF-sp |
chrX_-_107018969 | 0.69 |
ENST00000372383.4 |
TSC22D3 |
TSC22 domain family, member 3 |
chr10_+_111767720 | 0.69 |
ENST00000356080.4 ENST00000277900.8 |
ADD3 |
adducin 3 (gamma) |
chr16_+_20817761 | 0.69 |
ENST00000568046.1 ENST00000261377.6 |
AC004381.6 |
Putative RNA exonuclease NEF-sp |
chr21_+_34619079 | 0.68 |
ENST00000433395.2 |
AP000295.9 |
AP000295.9 |
chr10_-_27149904 | 0.68 |
ENST00000376166.1 ENST00000376138.3 ENST00000355394.4 ENST00000346832.5 ENST00000376134.3 ENST00000376137.4 ENST00000536334.1 ENST00000490841.2 |
ABI1 |
abl-interactor 1 |
chr7_+_7606497 | 0.68 |
ENST00000340080.4 ENST00000405785.1 ENST00000433635.1 |
MIOS |
missing oocyte, meiosis regulator, homolog (Drosophila) |
chr10_+_127408263 | 0.68 |
ENST00000337623.3 |
C10orf137 |
erythroid differentiation regulatory factor 1 |
chr4_+_75858290 | 0.67 |
ENST00000513238.1 |
PARM1 |
prostate androgen-regulated mucin-like protein 1 |
chr12_-_51566592 | 0.67 |
ENST00000257915.5 ENST00000548115.1 |
TFCP2 |
transcription factor CP2 |
chr6_+_30524663 | 0.67 |
ENST00000376560.3 |
PRR3 |
proline rich 3 |
chrX_+_55478538 | 0.67 |
ENST00000342972.1 |
MAGEH1 |
melanoma antigen family H, 1 |
chr19_+_16222439 | 0.66 |
ENST00000300935.3 |
RAB8A |
RAB8A, member RAS oncogene family |
chr16_+_30484021 | 0.66 |
ENST00000358164.5 |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr10_-_27149851 | 0.65 |
ENST00000376142.2 ENST00000359188.4 ENST00000376139.2 ENST00000376160.1 |
ABI1 |
abl-interactor 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 11.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 2.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 19.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 16.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 5.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 12.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 5.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 4.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 4.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.3 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.9 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 3.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 2.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 2.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 7.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
1.0 | 6.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
1.0 | 3.9 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.8 | 5.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 1.7 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
0.5 | 1.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 7.8 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 0.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.4 | 1.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.4 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 0.4 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.3 | 3.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 1.0 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.3 | 1.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 1.4 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.3 | 0.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 0.8 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.3 | 2.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 4.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.4 | GO:0032427 | GBD domain binding(GO:0032427) |
0.2 | 3.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 1.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 0.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.2 | 5.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 1.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 3.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 3.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 2.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 0.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.5 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.2 | 0.8 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 3.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 2.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 4.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 3.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 1.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.7 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 1.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.1 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.4 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.1 | 0.8 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.1 | 5.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 1.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.7 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 0.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 2.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.3 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.1 | 0.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.3 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 1.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 1.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.1 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.8 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) aspartic-type endopeptidase inhibitor activity(GO:0019828) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.1 | 0.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 1.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 2.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 2.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.5 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.2 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.1 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.3 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.0 | 0.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.2 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 1.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 1.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.2 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.1 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.0 | 0.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 1.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 1.2 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 1.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 3.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.5 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 1.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.8 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.8 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 2.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 1.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 1.8 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 2.3 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 1.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 1.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 2.7 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 0.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.0 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 9.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 1.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 4.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 8.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 2.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 15.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 7.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 7.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 3.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.0 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.8 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 1.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 2.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 3.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 2.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 1.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 1.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.0 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 1.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.6 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.9 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 1.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 2.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.5 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 5.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.1 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.8 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.0 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.3 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 7.7 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
1.2 | 4.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.7 | 5.5 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 4.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 1.4 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.4 | 3.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 5.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 4.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 4.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 1.0 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.3 | 6.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 3.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 0.8 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.3 | 1.3 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.3 | 0.8 | GO:0043291 | RAVE complex(GO:0043291) |
0.3 | 1.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 5.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 2.9 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 1.3 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 2.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 1.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.2 | 0.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 1.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 2.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.8 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 0.4 | GO:0061673 | cortical microtubule(GO:0055028) mitotic spindle astral microtubule(GO:0061673) |
0.1 | 9.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.7 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.1 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.5 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.4 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 1.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 1.2 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 0.3 | GO:0034455 | t-UTP complex(GO:0034455) |
0.1 | 0.3 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.1 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 1.3 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.6 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 1.5 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.4 | GO:0031095 | platelet dense tubular network(GO:0031094) platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.6 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 1.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.2 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.0 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 0.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 0.2 | GO:1990031 | pinceau fiber(GO:1990031) |
0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 1.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 2.4 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.7 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 6.0 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.2 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 11.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.4 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 1.0 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.0 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 2.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 4.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.6 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 2.4 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 1.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.7 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.5 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 2.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 1.0 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 2.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 1.3 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 1.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.2 | 4.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
1.2 | 1.2 | GO:1902227 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
1.1 | 4.3 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.9 | 3.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.7 | 3.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.7 | 3.5 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.6 | 3.7 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.6 | 3.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 4.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.5 | 1.6 | GO:0002316 | follicular B cell differentiation(GO:0002316) activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 4.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 1.3 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.4 | 1.7 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.4 | 5.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 2.4 | GO:0032596 | T cell antigen processing and presentation(GO:0002457) protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.3 | 1.7 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.3 | 1.6 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.3 | 1.0 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.3 | 0.3 | GO:0021997 | neural plate axis specification(GO:0021997) |
0.3 | 1.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.3 | 1.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.3 | 0.8 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.3 | 1.0 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.3 | 1.3 | GO:0033590 | response to cobalamin(GO:0033590) |
0.3 | 1.8 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.3 | 2.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.0 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.2 | 1.0 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 0.7 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.2 | 1.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 2.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 1.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 1.3 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.2 | 2.1 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 1.0 | GO:0051941 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.2 | 0.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 1.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 0.8 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 1.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.2 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.0 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.2 | 3.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.4 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.2 | 3.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.4 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 0.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 2.4 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.2 | 1.3 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 3.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 0.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.2 | 0.5 | GO:0001300 | chronological cell aging(GO:0001300) |
0.2 | 0.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.2 | 0.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
0.2 | 0.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.7 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.2 | 1.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.5 | GO:1903939 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of TORC2 signaling(GO:1903939) |
0.2 | 4.8 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.2 | 1.0 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.2 | 0.6 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.2 | 0.9 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 0.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 2.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 3.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 3.0 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.6 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.9 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 1.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.4 | GO:0032887 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.1 | 3.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.1 | 0.4 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 1.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.4 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.1 | 0.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.4 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.1 | 1.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 1.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.2 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 1.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.4 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 1.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.1 | 0.6 | GO:0035900 | response to isolation stress(GO:0035900) |
0.1 | 0.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 4.7 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.1 | 1.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 0.3 | GO:0072200 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm development(GO:0048389) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) pattern specification involved in mesonephros development(GO:0061227) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in kidney development(GO:0072098) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
0.1 | 0.3 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.1 | 0.3 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.1 | 0.5 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.3 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.1 | 0.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.5 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
0.1 | 1.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 0.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.5 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.1 | 2.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 9.7 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 2.6 | GO:0006625 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 1.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.3 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 1.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.1 | 0.3 | GO:0044878 | cleavage furrow formation(GO:0036089) mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 0.8 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 1.0 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.1 | 1.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.5 | GO:0003014 | renal system process(GO:0003014) |
0.1 | 1.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 2.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 1.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 1.1 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 1.3 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.5 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.5 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.2 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
0.1 | 0.8 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 5.6 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.5 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 1.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 1.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.3 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.1 | 0.1 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.1 | 0.1 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.3 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.1 | 0.3 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 1.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.4 | GO:0046543 | thelarche(GO:0042695) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.9 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.2 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.1 | 0.7 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.5 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 0.1 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.1 | 0.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.2 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 4.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.1 | GO:0090182 | negative regulation of pinocytosis(GO:0048550) regulation of secretion of lysosomal enzymes(GO:0090182) |
0.1 | 1.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.0 | GO:2000538 | negative regulation of T cell cytokine production(GO:0002725) T-helper 1 cell activation(GO:0035711) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.0 | 2.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 1.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.0 | 1.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.2 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.5 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.5 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.2 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.1 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 5.7 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.1 | GO:0045766 | positive regulation of angiogenesis(GO:0045766) |
0.0 | 0.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 1.1 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.0 | 1.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.6 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.0 | 1.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.0 | 5.3 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.1 | GO:1904529 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.0 | 1.2 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 1.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.8 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.0 | 0.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.0 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.5 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 1.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.0 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.0 | 0.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.0 | 0.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.2 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.7 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 1.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 1.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 1.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.1 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.2 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.4 | GO:0006516 | N-acetylglucosamine metabolic process(GO:0006044) glycoprotein catabolic process(GO:0006516) |
0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.4 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.0 | 0.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.0 | 0.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 1.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.7 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.0 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.0 | 0.3 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.0 | 0.1 | GO:0007568 | aging(GO:0007568) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.0 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.0 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.0 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.3 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.0 | 0.7 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.3 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 1.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.0 | 0.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.0 | GO:0043132 | NAD transport(GO:0043132) |
0.0 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.5 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 1.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 1.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.2 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.3 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.2 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.1 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.0 | 0.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.0 | 0.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.1 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) |
0.0 | 0.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.1 | GO:0007584 | response to nutrient(GO:0007584) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0046794 | transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) |
0.0 | 0.0 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 0.1 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.0 | GO:1903039 | positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.0 | 0.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043281) |
0.0 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 | 0.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.1 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.8 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.2 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |